Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.



Aclaris Therapeutics announced it raised $80 Million in an initial filing from an offering of $80 Million

Company Information

Related People

Funding Insights

Aclaris Therapeutics announced it raised $80 Million in an initial filing from an offering of $80 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information